Literature DB >> 9182694

Interaction between cAMP-dependent and insulin-dependent signal pathways in tyrosine phosphorylation in primary cultures of rat hepatocytes.

Y Ito1, Y Uchijima, M Ariga, T Seki, A Takenaka, F Hakuno, S I Takahashi, T Ariga, T Noguchi.   

Abstract

The present studies were undertaken to determine whether the interaction between cAMP-dependent and insulin-dependent pathways in primary cultures of rat hepatocytes affects biological functions and tyrosine phosphorylation. Quiescent hepatocytes were pretreated with dibutyryl cAMP or cAMP-generating agents such as glucagon, and then treated or not with insulin. Preincubation for 6 h with dibutyryl cAMP or glucagon enhanced the effect of insulin on DNA synthesis, but not the effect of insulin on amino acid transport or glycogen and protein synthesis. Tyrosine phosphorylation of intracellular proteins was determined by immunoblot analysis using an anti-phosphotyrosine antibody. Maximum tyrosine phosphorylation of a 195 kDa protein, which may be a substrate of insulin receptor kinase, of 175-180 kDa proteins, including insulin receptor substrate (IRS)-1, and of 90-95 kDa proteins, including the insulin receptor beta-subunit, was reached within 30 s of incubation with insulin. Pretreatment for about 3 h with dibutyryl cAMP or cAMP-generating agents clearly increased insulin-dependent tyrosine phosphorylation of the 195 kDa protein, but not IRS-1, IRS-2 or the insulin receptor beta-subunit. Because dibutyryl cAMP and cAMP-generating agents did not increase insulin receptor number or its kinase activity, the effect of cAMP on this potentiation of tyrosine phosphorylation is assumed to be exerted at a step distal to insulin receptor kinase activation. The potentiation by cAMP pretreatment of insulin-stimulated tyrosine phosphorylation may in part be secondary to inhibition of phosphotyrosine phosphatase activity, because cAMP pretreatment blunted the effect of Na3VO4 on the net tyrosine phosphorylation of the 195 kDa protein as compared with cells pretreated with no additive. In summary, the interactions between cAMP-dependent and insulin-dependent pathways that lead to augmentation of DNA synthesis appear to parallel the changes in tyrosine phosphorylation. Further studies will be required to determine whether there is a causal relationship between these phenomena.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9182694      PMCID: PMC1218442          DOI: 10.1042/bj3240379

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  32 in total

Review 1.  Molecular and cellular aspects of the insulin-like growth factor I receptor.

Authors:  D LeRoith; H Werner; D Beitner-Johnson; C T Roberts
Journal:  Endocr Rev       Date:  1995-04       Impact factor: 19.871

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Pleiotropic insulin signals are engaged by multisite phosphorylation of IRS-1.

Authors:  X J Sun; D L Crimmins; M G Myers; M Miralpeix; M F White
Journal:  Mol Cell Biol       Date:  1993-12       Impact factor: 4.272

4.  The level of insulin receptor tyrosine kinase activity modulates the activities of phosphatidylinositol 3-kinase, microtubule-associated protein, and S6 kinases.

Authors:  P A Wilden; C R Kahn
Journal:  Mol Endocrinol       Date:  1994-05

5.  Activation of the SH2-containing protein tyrosine phosphatase, SH-PTP2, by phosphotyrosine-containing peptides derived from insulin receptor substrate-1.

Authors:  S Sugimoto; T J Wandless; S E Shoelson; B G Neel; C T Walsh
Journal:  J Biol Chem       Date:  1994-05-06       Impact factor: 5.157

6.  Role of IRS-2 in insulin and cytokine signalling.

Authors:  X J Sun; L M Wang; Y Zhang; L Yenush; M G Myers; E Glasheen; W S Lane; J H Pierce; M F White
Journal:  Nature       Date:  1995-09-14       Impact factor: 49.962

7.  Serine/threonine phosphorylation of insulin receptor substrate 1 modulates insulin receptor signaling.

Authors:  J F Tanti; T Grémeaux; E van Obberghen; Y Le Marchand-Brustel
Journal:  J Biol Chem       Date:  1994-02-25       Impact factor: 5.157

Review 8.  Insulin action and the insulin signaling network.

Authors:  B Cheatham; C R Kahn
Journal:  Endocr Rev       Date:  1995-04       Impact factor: 19.871

9.  Involvement of phosphoinositide 3-kinase in insulin- or IGF-1-induced membrane ruffling.

Authors:  K Kotani; K Yonezawa; K Hara; H Ueda; Y Kitamura; H Sakaue; A Ando; A Chavanieu; B Calas; F Grigorescu
Journal:  EMBO J       Date:  1994-05-15       Impact factor: 11.598

10.  PTP-PEST: a protein tyrosine phosphatase regulated by serine phosphorylation.

Authors:  A J Garton; N K Tonks
Journal:  EMBO J       Date:  1994-08-15       Impact factor: 11.598

View more
  4 in total

1.  Signalling pathways of insulin-like growth factor-I that are augmented by cAMP in FRTL-5 cells.

Authors:  M Ariga; T Nedachi; M Akahori; H Sakamoto; Y Ito; F Hakuno; S Takahashi
Journal:  Biochem J       Date:  2000-06-01       Impact factor: 3.857

2.  Phosphatidylinositol 3-kinase (PI3K) activity bound to insulin-like growth factor-I (IGF-I) receptor, which is continuously sustained by IGF-I stimulation, is required for IGF-I-induced cell proliferation.

Authors:  Toshiaki Fukushima; Yusaku Nakamura; Daisuke Yamanaka; Takashi Shibano; Kazuhiro Chida; Shiro Minami; Tomoichiro Asano; Fumihiko Hakuno; Shin-Ichiro Takahashi
Journal:  J Biol Chem       Date:  2012-07-05       Impact factor: 5.157

3.  Molecular mechanisms of contraction-regulated cardiac glucose transport.

Authors:  M Till; D M Ouwens; A Kessler; J Eckel
Journal:  Biochem J       Date:  2000-03-15       Impact factor: 3.857

4.  Glucagon stimulates hepatic FGF21 secretion through a PKA- and EPAC-dependent posttranscriptional mechanism.

Authors:  Holly A Cyphert; Kimberly M Alonge; Siri M Ippagunta; F Bradley Hillgartner
Journal:  PLoS One       Date:  2014-04-14       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.